Bridgewater Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Bridgewater Advisors's PFE Position: Q1 2026 in Review
Bridgewater Advisors increased its Pfizer (PFE) stake by 3.8% in Q1 2026, buying an estimated $65.2K and bringing the position to 67,640 shares worth $1.76M. The position accounts for 0.1% of the portfolio, ranked #93.
Bridgewater Advisors first reported a position in PFE in Q4 2013 and has held it in 24 quarters since. The position peaked at $3.95M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Bridgewater Advisors held 67,640 shares of Pfizer worth $1.76M as of Q1 2026.
- Bridgewater Advisors bought 2,450 Pfizer shares in Q1 2026, an estimated $65.2K.
- Pfizer made up 0.1% of Bridgewater Advisors's portfolio in Q1 2026, its #93 holding.
- Bridgewater Advisors first reported a position in Pfizer in Q4 2013 and has held it in 24 quarters since.
- Bridgewater Advisors's Pfizer position peaked at $3.95M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.